Navigation Links
Cambrex Reports Fourth Quarter and Full Year 2009 Results
Date:2/10/2010

n two large capital projects for which the majority of work has since been completed.  

Steven M. Klosk, President and Chief Executive Officer, said, "We are pleased to finish 2009 at the high end of our prior earnings guidance, with just over $47 million in EBITDA.  We successfully managed working capital and expense levels throughout the business and reduced net debt by nearly $23 million during the year.

"As we entered 2009 the macro-economy suggested a conservative approach that led us to focus on reducing costs and maximizing cash flow.  While the outlook for the economy appears to have stabilized as we start 2010, our smaller customers continue to face a difficult funding environment and pricing pressures continue to exist in most product categories.  The 2010 forecasts for certain of our larger products are lower than we expected, and in some cases lower than 2009, for a variety of reasons.  We renegotiated an extension of an important contract for certain drug delivery products during the fourth quarter, and made price and volume concessions in order to maintain the majority of the share of this business over the next three years.  These are key factors contributing to our guidance of flat to lower sales and profits for 2010.

"We have opportunities to grow revenues through the advancement of projects in our pipeline of late stage development products, within our controlled substances and drug delivery categories and through the launch of new generic APIs.  However, we are convinced that we need to invest more aggressively, both internally and externally, in niche markets, novel technologies, and new geographies that generate sustainable growth.  Of course, we will continue to identify ways to further reduce costs and increase cash flow as we focus on growing the business."

'/>"/>

SOURCE Cambrex Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Cambrex Presentation at the JPMorgan Healthcare Conference to be Webcast
2. Cambrex to Announce Fourth Quarter and Full Year 2007 Financial Results on February 14, 2008
3. Cambrex Appoints Steven M. Klosk as President and CEO
4. Cambrex Reports Third Quarter 2008 Results
5. Cambrex Receives Notice Regarding NYSE Listing
6. Cambrex Reports First Quarter 2009 Results
7. Cambrex Continuous-Flow Microwave-Assisted Organic Synthesis Technology Nominated for 2009 Innovations Award
8. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
9. QMed, Inc. Reports July Medicare SNP Enrollments
10. Phlo Affiliate Reports Expanded Coverage to Oregon Border
11. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 15, 2014 Freeslate, Inc ., ... announced that Lupin Limited, one of India’s top five ... Protégé PharmD System for high throughput solid form ... focused on a wide range of quality, affordable generic ...
(Date:1/14/2014)... 2014 Carahsoft and CDS Federal Services ... 2014 at 2pm EST (11am PST), “Natural Language Processing: ... on how technology can turn raw, heterogeneous data into ... agencies. The online webinar will last approximately one hour. ...
(Date:1/14/2014)... 2014 EquitiesIQ, a leading informational research ... Alliqua is an emerging biomedical company acquiring, developing, manufacturing, ... market. , Free report download: http://equitiesiq.com/reports/alliqua/ , ... management team and Board, which launched the company’s new ...
(Date:1/14/2014)... In recent years, growing suspicion about the pharmaceutical ... and promotion has led to unprecedented levels of public ... about the insidious impact of commercialization of research, has ... the world’s biggest pharmas for illegal marketing activities, allegations ...
Breaking Biology Technology:Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Webcast - Natural Language Processing: Converting Raw Data into Actionable Knowledge – Hosted by Carahsoft and CDS Federal Services 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3
... Kansas Day of,Innovation featuring the fifth annual Great ... Thursday, September 4th, 2008 at the Wichita,Marriott, 9100 ... providing early stage, high-growth companies in Kansas with ... "This has grown to,be a dynamic event that ...
... 18 /Xinhua-PRNewswire/ --,Synutra International, Inc. (Nasdaq: SYUT, "Synutra"), ... producer, marketer and seller of,nutritional products for infants, ... its proposed public offering of its common stock,indefinitely., ... board has determined it is,in the best interest ...
... July 18 /PRNewswire/ - Norgen Biotek Corp., an ... for RNA, DNA and protein purifications, today announced ... new kits geared towards the,isolation of RNA and ... diagnostic,applications. In response to customer demands and emerging ...
Cached Biology Technology:2008 Kansas Day of Innovation Featuring the Fifth Annual Great Plains Capital Conference Scheduled for September 2Synutra Announces Postponement of Proposed Offering 2Norgen Biotek Corp. Launches Four New Kits for the Purification of RNA and DNA from Plants and Fungi 2
(Date:4/24/2014)... (LMU) in Munich have identified the structural features ... between viral and endogenous RNAs in living cells. ... of cellular metabolism and hijack cellular resources for ... dependent on viral RNA molecules that are delivered ... and/or newly synthesized in the host cell, and ...
(Date:4/24/2014)... with new insights into the make-up of tropical forests, ... Basin have revealed unprecedented detail of the size, age ... satellite maps with hundreds of field plots. , ... the amount of carbon each tree can store. This ... which trees are given a cash value according to ...
(Date:4/24/2014)... a welcome mat to bacteria seeking to invade, and scientists ... this week in the Proceedings of the National Academy ... microbe and host that researchers can exploit to protect plants. ... Arabidopsis puts out a molecular signal that invites ... army were unknowingly passing by a castle, and the sentry ...
Breaking Biology News(10 mins):Viral infections: Identifying the tell-tale patterns 2Viral infections: Identifying the tell-tale patterns 3Amazon rainforest survey could improve carbon offset schemes 2How a plant beckons the bacteria that will do it harm 2How a plant beckons the bacteria that will do it harm 3
... the womb? Previously, researchers assumed that consumption of "bad" ... growth and that "good" omega-3 fatty acids prevent expansive ... Universitt Mnchen showed no evidence to support this "perinatal ... epidemic with more and more younger children affected by ...
... Anatomists, 2012 Basmajian Award will be presented on April ... of cell biology, neurobiology and anatomy at the Medical ... at the AAA Annual Meeting at EB 2012 (Tuesday, ... Diego, CA)., This award recognizes health science faculty who ...
... PhytoKeys known for applying cutting ... is pioneering an electronic-only publishing workflow in a series ... of January 2012 (see related press release ). ... took effect to the way plant scientists name new plants, ...
Cached Biology News:Fish oil during pregnancy does not protect against excessive adipose tissue development 2Todd Hoagland honored by Anatomy Society for excellence in teaching, research & scholarship 2Early land plants: Early adopters! 2Early land plants: Early adopters! 3
... Situ Assay Kit is a fluorescent-based assay ... undergoing apoptosis. The kit is for research ... or therapeutic procedures. CHEMICON®s CaspaTag™ Pan-Caspase In ... to detect active caspases. The methodology is ...
... is a fluorescein-conjugated jetSI-ENDO ... at 520 nm), the powerful ... are used to determine the ... intracellular delivery and trafficking of ...
... Cellular uptake of long double stranded ... RNA interference in a diverse group of ... culture. RNA interference leads to the inhibition ... destruction of the target messenger RNA (mRNA). ...
... and reduced space requirements of the ... DNA analysis technology affordable .The benchtop ... of SEQUENOM's applications and assays, including: ... , Gene Expression Analysis (QGE) , ...
Biology Products: